Medical Countermeasures New Insights Into Tularemia Pathogen May Inform Next-Generation Medical CountermeasuresGlobal Biodefense StaffMay 14, 2026
Medical Countermeasures When Mpox Strikes the Eye: A Case for Combination Antiviral TherapyGlobal Biodefense StaffApril 16, 2026
Medical Countermeasures Smallpox Preparedness Contracts Top $60 Million as U.S. and International Partners Bolster Biodefense StockpilesGlobal Biodefense StaffMarch 25, 2026
Novel High-Density Microarray Patch Can Deliver Vaccines Directly to the Skin Medical Countermeasures March 17, 2020 …
Hotel Influenza: Research Heats Up on Universal Flu Vaccines Medical Countermeasures March 17, 2020 …
Regeneron and Sanofi Begin Global Clinical Trial for Use of Sarilumab in Severe COVID-19 Patients Medical Countermeasures March 16, 2020 …
Moderna Announces First Participant Dosed in Phase 1 Study of mRNA Coronavirus Vaccine Medical Countermeasures March 16, 2020 …
CEPI Gets €140 Million Funding Boost From Germany While Expanding Coronavirus Vaccine Search Medical Countermeasures March 13, 2020 …
Using Antibodies from COVID-19 Survivors to Protect Healthcare Workers and Patients Medical Countermeasures March 13, 2020 …
Janssen Scientists Collaborate with BIDMC Virology Lab to Accelerate COVID-19 Vaccine Development Medical Countermeasures March 13, 2020 …
XJTLU Research Indicates No Clinical Benefit for Corticosteroid Treatment of COVID-19 Medical Countermeasures March 13, 2020 …
AbCellera and Eli Lilly to Co-Develop COVID-19 Therapeutic Antibodies Medical Countermeasures March 12, 2020 …
DARPA P3 Researchers Race to Create Treatment for the Novel Coronavirus Medical Countermeasures March 11, 2020 …
Critical Bioeconomy Asset in Need of Attention: BSL-3 and BSL-4 Laboratories in the U.S. Medical Countermeasures March 6, 2020 …
Passive Immunization with mAbs Against Aerosolized Ricin Toxin Medical Countermeasures March 6, 2020 …
Soligenix Announces Successful Demonstration of Heat Stabilization for Filovirus Vaccine Platform Medical Countermeasures March 3, 2020 …
CureVac CEO Discusses Coronavirus Vaccine Development with White House Leadership Medical Countermeasures March 3, 2020 …
